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Natividad Blasco a,1,2, Aida Beà a,1, Gisel Barés a, Cristina Girón a, Raúl Navaridas b, 
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A B S T R A C T   
The apoptotic nuclease EndoG is involved in mitochondrial DNA replication. Previous results suggested that, in 
addition to regulate cardiomyocyte hypertrophy, EndoG could be involved in cell proliferation. Here, by using in 
vivo and cell culture models, we investigated the role of EndoG in cell proliferation. Genetic deletion of Endog 
both in vivo and in cultured cells or Endog silencing in vitro induced a defect in rodent and human cell prolif-
eration with a tendency of cells to accumulate in the G1 phase of cell cycle and increased reactive oxygen species 
(ROS) production. The defect in cell proliferation occurred with a decrease in the activity of the AKT/PKB-GSK- 
3β-Cyclin D axis and was reversed by addition of ROS scavengers. EndoG deficiency did not affect the expression 
of ROS detoxifying enzymes, nor the expression of the electron transport chain complexes and oxygen con-
sumption rate. Addition of the micropeptide Humanin to EndoG-deficient cells restored AKT phosphorylation 
and proliferation without lowering ROS levels. Thus, our results show that EndoG is important for cell prolif-
eration through the control of ROS and that Humanin can restore cell division in EndoG-deficient cells and 
counteracts the effects of ROS on AKT phosphorylation.   
1. Introduction 
Cell division or growth and cell’s mitochondrial function are mutu-
ally regulated in order to adjust energy supply and molecular precursors 
to each cell function. Also the switch between one and another depends 
on nutrient availability [1,2]. Mitochondrial electron transport chain 
(METC) activity has been directly correlated with cell division and 
inversely correlated with cell growth [1]. Cyclin D1 regulates mito-
chondrial respiration in cycling epithelial cells [3] and, recently, phos-
phorylation of METC complex I by Cyclin B/cdk1 has been shown to 
improve respiration and shorten cell cycle time [4]. Reactive oxygen 
species (ROS) generated by the METC are directly related to the control 
of cell proliferation in Drosophila [5] and redox signaling influences 
diverse aspects of normal cell function, particularly in the heart, as 
reviewed in Ref. [6]. High ROS production due to the increase of envi-
ronmental oxygen concentration after birth and ROS-induced sub-lethal 
DNA damage have been shown to trigger cardiomyocyte cell cycle arrest 
in neonatal mice [7]. However, the mediators and regulators naturally 
influencing ROS production and, hence, the effect of ROS on cell divi-
sion and growth have not been identified. 
EndoG is a nuclease that was first characterized in bovine heart 
mitochondrial extracts [8]. In addition to its implication in 
caspase-independent cell death [9], EndoG has been shown to influence 
mitochondrial DNA (mtDNA) replication in vitro [10] and DNA recom-
bination [11]. However, the relevance of EndoG in vivo was unclear 
because a first characterization of two independently generated 
Endog-deficient mice showed no overt phenotype [12,13]. We previ-
ously identified Endog as a determinant of cardiac hypertrophy [14] and 
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showed that spontaneously hypertensive rats, which naturally lack 
Endog expression, and Endog knockout mice, have increased ROS 
abundance in the heart and larger cardiomyocytes [14]. Our recent re-
sults show that EndoG is involved in the control of mtDNA replication 
and abundance, which influences mitochondrial ROS production, 
modulating cardiomyocyte size [15]. However the increase in car-
diomyocyte size did not fully translate into increased heart mass in 
Endog-deficient mice [14]. 
Oxidative stress influences cardiomyocyte division at birth [7], ROS 
control cell division in the fly [5] and Endog deficiency induces increased 
ROS abundance [14,15]. Therefore, we wanted to assess whether, in 
addition to influence cell size, EndoG function influences cell division 
and, if so, whether the effect is mediated by the control of ROS gener-
ation. In the present work, we analyzed the influence of EndoG in cell 
proliferation and characterized the signaling mediators controlling it, 
using different approaches to reduce Endog/ENDOG gene expression in 
different cell types; we also quantified ROS abundance and assessed 
their impact on the EndoG-dependent changes in cell signaling and 
proliferation. 
2. Materials and Methods 
2.1. Bioethics statement for Endog knockout mouse line and rat neonates 
The investigation with experimental animals was approved by the 
Experimental Animal Ethic Committee (CEEA) of the University of 
Lleida (codes CEEA06-01/10,07-01/10, 08-01/09 and 09-01/09), 
comply with the ARRIVE Guidelines and conforms to the Guide for the 
Care and Use of Laboratory Animals, 8th Edition, published in 2011 by 
the US National Institutes of Health. Endog mouse colony is derived 
from founders given by Dr. Michael Lieber, University of Southern 
California, LA, CA, USA (Irvine, R.A.; Adachi, N. 2005), have a C57BL/ 
6J background and was housed in Tecniplast GM500 cages (391 × 199 
× 160 mm) never exceeding 5 adults/cage. Rats used for neonatal car-
diomyocyte culture had a Sprague-Dawley background and were housed 
in conventional rooms. All animals were housed at the Experimental 
Animal Housing Facility—University of Lleida, lights on from 7 a.m. to 7 
p.m., temperature = 18–22 ◦C and 30–70% humidity. Enriched envi-
ronment included autoclaved cellulose material. Animals were fed 2914 
diet (Irradiated Teklad Global 14% Protein Rodent Maintenance Diet, 
Harlan) and sterilized tap water, both ad libitum. Wellbeing of animals is 
monitored daily by visual inspection and, for SPF housed mice, pathogen 
analysis is monitored from sentinel animals in periods of 8 weeks 
following the standards determined by the Federation of European 
Laboratory Animal Science Association (FELASA). Adult mice and 
neonatal rat pups were sacrificed following the Guidelines of our CEEA. 
2.2. Heart cardiomyocyte cell counting, histological procedures and 
primary cell culture 
Mouse hearts were dissected, weighted and cardiomyocytes were 
counted as previously described [16]. Briefly, hearts were dissected and 
formol-fixed at 4 ◦C followed by a treatment with 12.5 M KOH overnight 
at 4 ◦C. After a 10min vortex to dissociate the cells, they were passed 
through a 250 μm mesh, centrifuged, suspended in phosphate buffered 
saline (PBS) and cardiomyocytes were counted using a Neubauer 
chamber. Cardiomyocytes in the counting chamber were distinguished 
from fibroblasts and debris by cytoplasmic size and cell shape. Immu-
nohistochemistry was performed in paraffin-included heart slices as 
previously described [16] using primary antibodies against Ki67 
(MAB4190, Merck) and Cyclin D (SC-20044), biotinylated secondary 
antibodies (Jackson) and developed with deaminobenzidine (DAB, 
DAKO) contrasted with hematoxylin. Microscopic images were obtained 
using a Leica DMD108 microscope and 1000–2000 nuclei were assessed 
for Ki67 staining/mouse using ImageJ software (Wayne Rasband, NIH). 
Rat and mouse neonatal cardiomyocyte cultures were performed as 
previously described [17], using all available pups (usually 2–3 pups per 
genotype), and purity was assessed by fluorescent detection of α-sarco-
meric actinin (A7811, SIGMA) visualized with an Olympus IX70 vertical 
epifluorescence phase-contrast microscope. Methods for neonatal mouse 
cardiomyocyte and fibroblast cultures were adapted from Bahi et al., 
2006 [18]. 
2.3. Cell lines 
Human embryonic kidney cell line HEK293 (CRL-1573) and Rat-1 
(CRL-2210) rat fibroblasts were purchased from the American Type 
Culture Collection. All reagents for cell culture were from GIBCO. All cell 
lines were grown in Dulbecco’s modified Eagle medium (#41965-039) 
supplemented with 10% fetal bovine serum and, except for Rat-1 cells, 
also supplemented with 1 mmol/L HEPES (#15630-056), 1 mmol/L 
sodium pyruvate (#11360-039), 2 mmol/L L-glutamine (#25030-024), 
1 mmol/L MEM NEAA (#11140-035) and 100 U/ml of penicillin/100 
μg/ml streptomycin (#15140-122) at 37 ◦C with saturating humidity 
and 5% CO2. All experiments were conducted with low passage cells 
from recently resuscitated frozen stocks. 
2.4. Modification of ENDOG/Endog expression in cultured cells 
To reduce EndoG expression in cultured cells, two approaches were 
used. Lentiviral vector pLVTHM (Dr. Trono’s lab., Switzerland) con-
taining small hairpin RNA interference sequences targeting different 
regions of the rat EndoG mRNA sequence were prepared as previously 
described and used to silence Endog expression in Rat-1 cells. Endog 
shRNA1 construct targets the sequence 5′-GGAACAACCTTGAGAAGTA- 
3′ and Endog shRNA2 is against the sequence 5′-GCAGCTTGACTC-
GAACTTA-3’. A lentiviral vector containing a scrambled sequence from 
shRNA1 was used as control [15]. ENDOG expression was disrupted in 
human HEK293 cells by CRISPR-Cas9 based gene scission and repair. In 
brief, we selected four sequences (5′-CCGGCCATGCGGGCGCTGCGG 
GC-3′, 5′-CCGGCCCGCAGCGCCCGCATGGC-3′, 5′-CCCGACGCCAGGGT 
CAGGCCGGC-3′ and 5′-CCGGGACTGCTGGGCCGGCTGCC-3′), spanning 
the first third of the ENDOG ORF within exon 1, for their use as 
single-guide RNAs (sgRNA1 to 4). Of note, ENDOG exons 2 and 3 overlap 
with the 5′UTR of SPOUT1 (UniProt Q5T280). Each sequence was 
subcloned in the BsbI site of the pSpCas9(BB)-2A-GFP vector (Addgene), 
which contains the rest of the sgRNA scaffold and also includes the Cas9 
nuclease ORF [19]. In addition, we generated a PCR construct con-
taining 1 kb-sequences at 5′ and 3′ of the Endog gene region containing 
the target sgRNA sequences, flanking the puromycin resistance ORF 
(PuroR). In the cells, this DNA fragment would disrupt the ENDOG gene 
after insertion of the PuroR sequence by homology-directed repair after 
Cas9-driven gene scission at the locus determined by the sgRNAs. This 
fragment was agarose gel-purified and co-transfected with the vector 
containing the sgRNA and Cas9 sequences in HEK293 cells growing in 
96-well culture plates. Puromycin was added five days after transfection 
and wells containing single puromycin resistant cell clones were selected 
and expanded. Several HEK293 clones for each sgRNA (1–4) were 
PCR-tested for the recombination event and ENDOG expression was 
checked by qPCR and Western Blot. Cell proliferation and ROS pro-
duction were compared between control cells and one positive clone per 
each sgRNA. 
2.5. Glutathione, N-Acetyl-Cysteine, MitoTEMPO™, ethidium bromide 
and humanin treatments 
L-Glutathione reduced (GSH, Sigma-Aldrich; G4251) was stored at 
163 mM and prepared at a concentration of 2 mM in culture medium at 
the time of the experiment, as previously described [15,20]. The Su-
peroxide dismutase (SOD) mimetic MitoTEMPO™ (Sigma-Aldrich; 
SML0737) was stored at 20 mM, prepared in water and added to the 
culture at a final concentration of 25 μM during 24 h [15,21]. 
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N-Acetyl-L-cysteine (NAC, Sigma-Aldrich; A7250), a ROS scavenger, was 
dissolved in complete DMEM media to produce a 612 mM stock solution. 
Following filter sterilization (0.2 μm pore-size filters), NAC was added to 
the cell media at a concentration of 0.2 mM during the time required 
according to the experimental design, as previously described [15]. In 
order to reduce the mitochondrial DNA (mtDNA) content, cells were 
cultured with Ethidium bromide solution (EtBr) 25 ng/ml (Sigma-Al-
drich; E1510) during 1 week until the cells approached a state con-
taining 10–20% of the normal amount of mtDNA as previously described 
[15]. Lyophilized Humanin peptide, sequence MAPRGFSCLLLLT-
GEIDLPVK (custom synthesized, purity>91%; GenScript, USA) was 
reconstituted in DMSO to obtain a 10 mM stock solution that was sub-
sequently dissolved in culture media to obtain the final working con-
centration [15]. 
2.6. Silencing of Romo1 expression 
Romo1 gene silencing was achieved in cultured mouse fibroblasts by 
lentiviral transduction of validated pLKO.1 vector-subcloned Romo1 
shRNA sequences (MISSION® SHCLNG-NM_025946, SIGMA). Romo1 
silencing vas verified at the time indicated in the figure legend by RT- 
qPCR using the TaqMan specific probe Mm01604571_g1 (Thermo- 
Fisher). 
2.7. Cell proliferation analysis 
Equal number of cells were seeded from low passage plates (lower 
than 20 in the case of cell lines and 2 passages from tissue dissection in 
the case of primary cultures). For gene silencing experiments, lentiviral 
transduced cells were incubated 3 days and after trypsinization, cells 
were seed at equal densities. In every experiment, cells from 2 plates 
were counted a few hours after seeding to confirm equal initial cell 
number. This was the time of drug/vehicle addition if required. Cultures 
were let to grow during 48–72 h. At the end of the period, plates were 
rinsed with PBS and trypsinized. After mild centrifugation, pellets were 
resuspended in PBS and counted in a Neubauer cell chamber under a 
phase contrast microscope. The exact number of independent experi-
ments performed in duplicate is specified in the figure legends. 
2.8. Quantification of ROS 
ROS production was determined by using the fluorescent probe 
MitoSOX™ Red, a cationic derivative of DHE, which is rapidly and 
selectively targeted to the mitochondria where, as stated by the manu-
facturer, it is oxidized mainly by superoxide anions (O2.− ) (Thermo Fisher 
Scientific; M36008). We have used previously MitoSOX™ Red to detect 
mitochondrially generated superoxide anions by flow cytometry [15]. In 
brief, cells were washed twice in PBS, trypsinized and counted using a 
Neubauer cell chamber. Equal amount of cells from each population 
were incubated in PBS containing 2,5 μM MitoSOX™ Red for 10 min. 
Fluorescence of the cell population is proportional to the levels of 
intracellular ROS generated and measured with a BD FACSCanto II cy-
tometer (Becton Dickinson, Mountain View, CA, USA) using 488 nm 
laser excitation and detection with BP 585/42 filter. For some control 
experiments we also used DHE (Sigma-Aldrich; D7008), and 
Dihydrorhodamine-123 (SIGMA; D1054), a probe that, following the 
manufacturer’s instructions, localizes in the mitochondria and emits 
green fluorescence when oxidized. 
2.9. Cell cycle analysis 
Cells were seeded in 60-mm petri dishes at 1.25–2.5 × 106 cells/dish, 
left to adhere and treated as indicated. Afterward, cells were trypsinized 
and washed in ice-cold PBS, fixed in 70% ethanol and stored at –20 ◦C 
until analysis. Fixed cells were suspended in 500 μl propidium iodide 
(PI)/RNase staining buffer (Becton Dickinson, Franklin Lakes, NJ, USA), 
incubated for 30 min at 37 ◦C and analyzed in a BD FACSCanto II cy-
tometer (Becton Dickinson) as in previous works [20]. Data analysis was 
performed using ModFit LT software (Verity software house, Topsham, 
ME, USA). 
2.10. Analysis of gene and protein expression 
Total RNA extraction from cell cultures and reverse transcription 
were performed as described [16,18] and quantitative Real Time PCR 
was performed in a iCycler iQ PCR detection system and iQ v.3 and iQ 
v.5 software (BioRad), using the TaqMan Gene Expression Master Mix 
(Applied Biosystems Cat.N. 4369016) and specific Gene Expression As-
says from Applied Biosystems to amplify the transcripts of human 
and/or rodent ENDOG/Endog, Romo1, Irf7 (Mm00516788_m1) and 
Isg15 (Mm01604571_g1). Gene expression calculations were carried out 
as described previously for other genes [16]. Protein extraction, 
SDS-PAGE in standard polyacrylamide gels and Western Blot were per-
formed and analyzed as described elsewhere [16,18]. Antibodies were 
against human and rodent EndoG (ab76122, Abcam), pAkt (#4060, Cell 
Signaling), Akt (sc-1618, Santa Cruz Biotechnology), pGSK3 (9331, Cell 
Signaling), GSK3 (ab18893, Abcam), pCDK1 (ab18, Abcam), CDK1 
(ab32384 Abcam), Cyclin D (SC-20044 Santa Cruz Biotechnology), 
Cyclin B (ab181593, Abcam), HDAC4 (SC-11418, Santa Cruz Biotech-
nology), GAPDH (ab8245, Abcam), Lamin A/C (ab8984, Abcam) and), 
Catalase (sc-271803, Santa Cruz Biotechnology), MnSOD (sc-133134, 
Santa Cruz Biotechnology), Complex I (NDUFS3; 459130, Invitrogen), 
Complex II (SDHα; a11142, Molecular Probes), Complex III (Core 2; 
a11143, Molecular Probes), Complex IV (Cox4; A21348, Thermo Fisher) 
and Complex V (F1F0; a21350, Molecular Probes). 
2.11. Coenzyme Q quantification 
Primary neonatal skin fibroblasts were seeded in 100-mm petri 
dishes and let to grow until 80–90% confluence. To collect the cells for 
the extraction, cells were scrapped with ice cold PBS, centrifuged at 
1000 g for 5 min at 4 ◦C and the pellet was stored at − 80 ◦C until the day 
of the extraction. For total CoQ determination, cells were disrupted by 
adding sodium dodecyl sulphate (1%) in PBS and immediately vortexing 
during 1 min. One hundred of CoQ6 was added as internal control to 
check extraction procedure. Ethanol: isopropanol (95:5) in a proportion 
2:1 was added and mixed again during 1 min. Organic extraction was 
performed with 600 μl of hexane. Mixture was vortexed again during 1 
min and centrifuged at 1000×g for 10 min 4 C. The upper organic phase 
was removed and stored. Organic extraction was repeated twice. All the 
organic phases were pulled and dried with speed-vac at 35 ◦C. Dried 
lipid extract was dissolved in 60 μl ethanol and injected in duplicate in a 
Beckman 166-126 HPLC system (Beckman Coulter, Brea, CA, USA) 
equipped with a 20 μl loop and a 15-cm Kromasil C-18 column (Sigma 
Aldrich, Barcelona, Spain) maintained at 40 ◦C. CoQ was separated in a 
flux of 1 ml/min of mobile phase of 65:35 methanol/2-propanol y 1.42 
mM lithium perchlorate. Total levels of CoQ were detected by an elec-
trochemical detector and expressed as pmol/mg protein. For redox ratio 
between CoQred/oxidized, Cells were homogenized in potassium- 
phosphate buffer. To 91.5 μl of sample, 3.5 μl mercaptoethanol and 5 
μl internal standard were added to avoid oxidation and control extrac-
tion. Then, 300 μl propanol was added to the mixture and vortexed 30 s. 
After 3 min of incubation, mixtures were vortexed again and centrifuged 
at 12.000×g for 1 min. Upper phase was immediately injected into a 100 
μl loop of HPLC as indicated previously [22]. Determination of the 
CoQH2/CoQ was performed by using the electrochemical detector. Data 
are from three independent experiments including 3 Endog+/+ and 3 
Endog− /− mice. 
2.12. Nucleoid analysis 
For immunofluorescence detection of dsDNA (ab27156, from 
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Abcam) and TOM20 (sc-11415, from Santa Cruz Biotechnology), cells 
were plated on 12 mm diameter coverslips in 24-well plates, 15.000 
cells/well to obtain 50–70% confluence upon fixation next day. Cells 
were fixed with 4% paraformaldehyde (PFA) for 20 min and washed 
twice with PBS. Then they were permeabilized with buffer A (0.1% 
Triton X-100, 3% FBS in PBS) for 30 min, and coverslips were incubated 
for 10 min with buffer B (0.05% Saponin, 2% FBS in PBS) to allow 
moderate permeabilization and blocking of the fixed cells. Then, cov-
erslips were incubated with primary antibody drops (prepared in Buffer 
B at a dilution of 1:400) in a dark wet chamber for 30 min, washed three 
times for 10 min with Buffer B, and incubated with secondary antibody 
drops (prepared in Buffer B at a dilution of 1:800) in a dark wet chamber 
for 30 min. Finally, cells were washed three times for 10 min with Buffer 
B, nuclei were stained with Hoechst for 10 min and washed twice with 
PBS. Nucleoid microscope images were obtained using ZEISS Elyra 7 
super-resolution microscope at x64 magnification. Nucleoid number and 
size quantification was performed with the ImageJ plugin 3D Object 
Counter, while co-localization quantification between dsDNA-TOM20 
was performed with JACoP plugin, establishing the same thresholds 
for each plugin in each image. All quantifications were done on stacks of 
images. Representative images are a maximum intensity projection of all 
stacks. Nucleoid number and size were quantified in 42 dermal fibro-
blasts per genotype from 6 independent animals. 
2.13. Statistical analysis 
Statistics were performed with GraphPad Prism (GraphPad Software, 
San Diego, CA, USA). The effect of Endog expression on the experimental 
values was assessed by the Student’s t-test. The effect of Endog expres-
sion in gene expression in Fig. 7B was performed by the Mann-Whitney 
U test. The Kruskal-Wallis test was used to analyze changes in Mito-
SOX™ fluorescence due to Endog expression and NAC addition (Fig. 1 D, 
G, J) and gene expression in tissues from Endog+/+ and Endog− /− mice 
(Fig. 7C and D), followed by the Dunn’s test for selected post hoc com-
parisons. Moreover, one-way analysis of variance (ANOVA) followed by 
the Bonferroni test was performed to determine the impact of Endog 
expression in cell cycle in different experimental groups, and two-way 
ANOVA was performed to determine the impact of Endog expression 
and gender or drug addition or gene silencing on the experimental 
values and for possible interaction. Experiments were performed at least 
three times in duplicates; the exact number is specified in each figure 
legend. All statistical tests were two-sided at a significance level of 
<0.05. 
3. Results 
3.1. EndoG deficiency restrains cell proliferation in the developing mouse 
heart 
Previous results showed that Endog is a blood pressure-independent 
cardiac hypertrophy candidate gene, which regulates mitochondrial 
function and cardiomyocyte growth [14]. We also found that neonatal 
[15] and adult [14] Endog− /− mice have abnormally big cardiomyocytes 
but this was not fully translated into a bigger heart mass. This apparent 
paradox prompted us to further investigate the role of EndoG in the 
heart. We counted cardiomyocyte number and found that Endog defi-
ciency was associated with a 33% decrease in cardiomyocyte number 
(Fig. 1A). Bigger cardiomyocyte size (Fig. 1A, right images), was not 
associated with a significant difference in heart weight in Endog− /− mice 
(Fig. 1B). This made us to suspect that hearts of Endog− /− mice were 
hypoplastic. A fraction of postnatal cardiomyocytes still proliferate after 
cell isolation and plating, therefore we analyzed the percentage of 
proliferating cells by immunodetection of Ki-67, which is broadly used 
as a proliferation marker. Our results showed a reduction in the number 
of cardiomyocyte nuclei expressing Ki-67 in Endog− /− cells (Fig. 1C). 
Consistent with our previous results in adult mice, our data showed 
increased ROS production in neonatal Endog− /− cardiomyocytes 
compared to wild type myocytes (Fig. 1D), which was diminished by the 
addition of the antioxidant compound N-Acetyl-L-Cysteine (NAC) 
(Fig. 1D). Endog-specific gene silencing in a culture of rat neonatal 
cardiomyocytes caused a reduction in cell number at 72 h, which was 
hampered by NAC addition (Fig. 1E). Taken together, these results 
showed that EndoG is involved in the regulation of cell division and 
growth in the developing rodent heart. 
3.2. EndoG deficiency limits proliferation of rodent and human dividing 
cells 
Despite its high expression in striated muscle, Endog is also expressed 
in many other tissues [14,17]. We posited that the influence of EndoG in 
cell division was broad and affected other cell types. Primary dermal 
fibroblasts from Endog− /− neonates proliferated more slowly than those 
from wild type mice in vitro, and NAC addition restored normal ROS 
levels and proliferation (Fig. 1F–H). The mitochondrial origin of ROS 
generated in EndoG-deficient cells was also assessed using the 
mitochondria-specific ROS probe Dihydrorhodamine-123 (Rho123) 
(Suppl. Fig. 1A and B). ROS levels and cell proliferation were partially 
normalized in EndoG-deficient primary fibroblasts by Glutathione 
(GSH) and MitoTEMPO™, which induced ROS neutralization, in addi-
tion to NAC (Suppl. Fig. B, C), supporting the role of ROS in reducing cell 
proliferation. We then checked whether EndoG had a similar function in 
cycling human cells. ENDOG-specific lentiviral-driven gene silencing in 
the human cell line HEK293 only achieved a 50% reduction of ENDOG 
expression and, under these conditions, we did not detect changes 
neither in ROS abundance nor in cell division. Therefore, we designed a 
CRISPR-Cas9-based strategy to disrupt ENDOG in these cells (Fig. 1I). 
Complete lack of ENDOG induced accumulation of ROS (Fig. 1J) and 
reduced cell proliferation in two different ENDOG-deficient clones 
(Fig. 1K). The coinciding results of all these approaches _ in vivo and in 
vitro gene targeting and gene silencing_ discarded the possibility that 
reduced proliferation was due to the alteration of an overlapping gene 
[23] and gave support to a role of ENDOG in the control of cell prolif-
eration. Addition of 0.2 mM NAC diminished ROS production and 
partially reversed the effect on cell proliferation pointing out to a 
mediator role of ROS in the effect of ENDOG silencing on HEK293 pro-
liferation (Fig. 1K). 
3.3. The effect of EndoG deficiency on cell proliferation depends on the 
mitochondrial DNA content 
Our previous results showed that EndoG deficiency impairs mtDNA 
replication [15]. We wanted to determine whether the effects of EndoG 
deficiency on cell proliferation were dependent on the mtDNA content. 
To explore this, we used the rat fibroblast cell line Rat-1. EndoG-defi-
cient Rat-1 cells reduced cell proliferation in a ROS-dependent manner 
as demonstrated by addition of the ROS scavenger NAC (Fig. 2A). 
Increased production of ROS triggered by Endog silencing in Rat-1 cells 
was confirmed by DHE (Suppl. Fig. 1D) and the mitochondria-specific 
probes MitoSOX™ (Fig. 2B), and Dihydrorhodamine-123 (Rho123) 
(Suppl. Fig. 1E). The increase in ROS production and the reduction in 
cell proliferation caused by EndoG deficiency was partially abolished by 
addition of the ROS scavengers NAC, GSH and MitoTEMPO™ (Suppl. 
Fig. 1E and F). We selected this cell line for the study of the impact of 
mtDNA on the effects of EndoG deficiency because primary mouse fi-
broblasts used previously did not maintain proliferation during the 
process to reduce their mtDNA content by exposure to ethidium bromide 
(EtBr) [15], and HEK293 cells viability was compromised when exposed 
to the same treatment. On the contrary, Rat-1 cells still proliferated at a 
rate of 0.5 duplications/day when their mtDNA was reduced enough as 
for reducing COXIV expression, a mitochondrially encoded protein 
(Fig. 2C and D). Silencing of Endog expression using two independent 
constructs had no effect on cell proliferation in EtBr-treated cells 
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Fig. 1. Analysis of the impact of Endog expression in cell proliferation and ROS abundance in diverse mouse, rat and human cell types. A) Cardiomyocyte (CM) 
number was counted from 5 to 9 hearts of Endog+/+ and Endog− /− of 4-days-old (P4) male and female mice (representative images shown at right), after digestion of 
the ventricular tissue that was previously weighted (B). C) Quantification of the expression of the proliferation-related Ki-67 nuclear antigen in histological ven-
tricular tissue preparations from P4 Endog+/+ and Endog− /− mice. Ki-67+ nuclei were counted in 3 different slices from 3 hearts/genotype and data are expressed as 
Ki-67+ nuclei/total nuclei in the slice. All individual quantifications are plotted (1000–2000 nuclei/genotype). D) MitoSOX™ fluorescence was quantified by flow 
cytometry in preparations of ventricular cardiomyocytes from P4 Endog+/+ and Endog− /− mice cultured in the presence or absence of 0.2 mM N-Acetyl-Cysteine 
(NAC; n = 6). E) Neonatal rat ventricular cardiomyocyte cultures were left untreated (NT, not transduced), transduced with a scrambled sequence (Scr) or an Endog- 
specific silencing sequence (shRNA) and then treated or not with 0.2 mM NAC for 48 h. Cells were fixed and stained with muscle-specific α-actinin (cardiomyocytes) 
and Hoechst dye (nuclei). Cardiomyocytes were counted in 10 different microscopic fields/treatment in 4 independent experiments. All 40 values/treatment are 
plotted. F) Skin fibroblasts were obtained from P4 Endog+/+ and Endog− /− mice, plated and amplified. Equal number of cells were seeded in 2 plates/genotype and 
counted after 72 h. Data are expressed as the number of cell cycles completed in 72 h.Cells in replicate plates were counted at time zero to confirm equal initial cell 
number. All values from 4 independent experiments are plotted. G) MitoSOX™ fluorescence was quantified as in (D) in preparations of Endog+/+ and Endog− /−
fibroblasts treated or not with NAC. H) Endog+/+ and Endog− /− fibroblasts were seeded in presence or absence of NAC and counted after 48 h. Conditions are as in F. 
I) Strategy for the CRISPR-Cas9-dependent ENDOG gene truncation by insertion of the puromycin resistance cassette (PuroR), using homologous recombination in 4 
different selected sites within the ENDOG gene in HEK293 human cells. Expression of ENDOG was analyzed in control cells (C) and several clones from each of the 
four PuroR insertion sites (see Material and methods section). J) MitoSOX™ fluorescence was quantified as in (D) in preparations of control cells and cells from 
CRISPR-Cas9-treated clones 1.1 and 4.3 treated or not with 0.2 mM NAC (n = 7). K) HEK293 cells were counted in control and ENDOG-deficient cultures from clones 
1.1 and 4.3 cultured for 48 h, treated or not with NAC. Proliferation was expressed as cell cycles completed in 48 h. Data plotted are from four experiments performed 
in duplicates. Graphs show experimental values plus mean ± SD, except D, G and J where median ± interquartile range is depicted. Analysis of the effect of Endog 
expression in the experimental values was performed with the Student’s t-test (B, C and F). 2-way ANOVA was used to analyze the influence of Endog expression and 
gender (A) or NAC treatment (E, H and K) and the interaction between them in cell number. The Kruskal-Wallis test was used to compare the effects of Endog 
expression and NAC addition on MitoSOX™ fluorescence followed by the Dunn’s test for selected post hoc comparisons (D, G and J). ns = not significant; *, p < 0.05; 
**, p < 0.01; ***, p < 0.001. 
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compared to scrambled-transduced cells (Fig. 2D). In parallel, no in-
crease in ROS production was observed by EndoG silencing in mtDNA 
depleted cells (Fig. 2E). These data suggest that the capability of EndoG 
to influence cell proliferation could be indirect and dependent on its 
function in mtDNA replication. 
3.4. Proliferation slow down induced by EndoG deficiency associates with 
accumulation of cells in the G1 phase of the cell cycle 
In order to characterize the intracellular events leading to cell cycle 
slow down induced by EndoG deficiency, we first analyzed the distri-
bution of actively dividing cells throughout the main phases of cell cycle 
and the influence of Endog expression. Cells with reduced expression of 
Endog (Endog-specific shRNA-treated Rat-1 fibroblasts) or completely 
lacking its expression (primary Endog− /− fibroblasts, ENDOG-directed 
CRISPR-Cas9-treated HEK293 cells) tended to accumulate in the G1 
phase compared to their respective controls (Fig. 3A–C). 
The above results lead us to analyze the expression of key regulators 
of cell cycle. Akt/PKB kinase regulates a plethora of intracellular events 
influencing cell metabolism, cell growth and cell division [24]. Akt 
transduces signals regulating cell division through the control of GSK-3β 
activity [25]. We assessed Akt phosphorylation at S473 (active Akt) and 
Akt-dependent GSK-3β phosphorylation at S9/S21 (inactive GSK-3β) in 
hearts of Endog+/+ and Endog− /− neonates at day 0 and day 3 post-
partum (P0, P3), and we found lower amount of p-Akt and p- GSK-3β in 
EndoG-deficient hearts at both ages compared to wild type hearts 
(Fig. 4A). These events were associated with reduced Cyclin D expres-
sion (Fig. 4A), in accordance with the hypoplasty of EndoG-deficient 
myocardium. Interestingly, phosphorylation of CDK1 (cyclin-depend-
ent kinase-1 or cdc2, cell division control protein 2 homolog) and 
expression of Cyclin B were only reduced in Endog− /− P3 hearts 
compared to controls but not at P0 (Fig. 4A). Cyclin D expression was 
also analyzed by immunostaining in P4 heart histological samples, 
corroborating a decrease in Cyclin D abundance in Endog− /− hearts 
compared to Endog+/+ samples (Fig. 4B). Expression analysis of these 
proteins in Rat-1 fibroblasts and HEK293 cells were in agreement with 
the results obtained in neonatal hearts, confirming the association of 
reduced Endog expression with lower Akt and GSK-3β phosphorylation 
and lower expression of Cyclin D (in Rat-1 cells) and Cyclin E (in 
HEK293 cells, in which Cyclin D was not detected) (Fig. 4C and D, 
respectively). These results showed that EndoG deficiency affects the 
progression through the G1 phase of cell cycle and suggest that this 
event involves a reduced activity of the Akt/GSK-3β axis, which in-
fluences the expression of G1 cyclins D and E. 
Fig. 2. Analysis of the influence of Endog expression 
in cell proliferation and ROS production in the Rat-1 
cell line, and its dependence on the abundance of 
mitochondrial DNA. A) Equal number of Rat-1 con-
trol cells (NT, not transduced), scrambled-transduced 
(Scr) cells and cells transduced with either of two 
independent Endog silencing constructs were seeded 
in duplicates and the number of cells after 48 h was 
counted. Data are expressed as the number of cell 
cycles completed in 48 h in the presence or absence of 
the ROS scavenger NAC (0.5 mM). All values from 3 
independent experiments are plotted plus mean ± SD. 
B) MitoSOX™ fluorescence was quantified by flow 
cytometry in preparations of the same experimental 
groups as in (A). C) Rat-1 cells were pre-treated with 
EtBr to reduce the mitochondrial DNA (mtDNA) 
content (see Materials and Methods section for de-
tails). Then, normal cells and EtBr-treated cells (EtBr) 
were transduced with scrambled (Scr) or two inde-
pendent Endog-specific silencing constructs (Endog 
shRNA1, 2). Western Blot of EndoG assessing the ef-
ficacy of the silencing constructs and COXIV expres-
sion assessing the effect of EtBr treatment on mtDNA 
depletion, performed with samples of control and 
EtBr-treated cells not transduced (NT) or transduced 
with the different constructs. GAPDH was used as 
loading control. D) Equal number of control and EtBr- 
treated Rat-1 cells were seeded, left not transduced 
(NT) or transduced with scrambled (Scr) or Endog- 
directed silencing constructs (Endog shRNA1 and 2) 
in duplicate plates/treatment and counted after 48 h. 
Data are expressed as the number of cell cycles 
completed in 48 h. All values from 3 independent 
experiments in duplicates are plotted plus mean ±
SD. E) MitoSOX™ fluorescence was quantified by 
flow cytometry in preparations of control not trans-
duced cells (NT) or EtBr-treated cells not transduced 
(NT) or transduced with scrambled (Scr) or Endog- 
directed silencing constructs (Endog shRNA1 and 2). 
Values of four independent experiments are plotted 
plus mean ± SD. Two-way ANOVA was used to 
analyze the influence of Endog expression and NAC 
treatment (A, B) or EtBr treatment (D) and the 
interaction between them in cell proliferation and 
ROS production. Ns: not significant; *, p < 0.05; **, p 
< 0.01; ***, p < 0.001.   
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In order to find out whether Akt-mediated signal transduction profile 
observed in EndoG-deficient cells was influenced by increased ROS 
abundance, we cultured a HEK293 clone lacking ENDOG expression 
(sgRNA1.1) in the presence or absence of the ROS scavenger NAC and 
analyzed the potential changes in cell signaling. We observed a transient 
recovery of pAkt/Akt, pGSK-3β/GSK-3β ratios and β-catenin and cyclin 
expression (Fig. 4E). Together, these results suggested an upstream role 
of ROS in the signal transduction linking EndoG deficiency with its 
biological effects on cell proliferation. 
The relevant implication of ROS in the control of cell proliferation by 
EndoG prompted us to investigate the reason for their accumulation in 
EndoG-deficient cells. Despite the existence of ROS-dependent regula-
tion of antioxidant enzymes [26,27], the major ROS metabolizing en-
zymes catalase and MnSOD were expressed at similar levels in 
fibroblasts from Endog+/+ and Endog− /− mice (Fig. 5A). Due to the fact 
that the METC activity is a major source of ROS and that EndoG regu-
lates mtDNA replication and abundance [15,28], which contains genes 
codifying for several components of the METC, we checked the expres-
sion of several mitochondrial- and nuclear-encoded METC complex 
subunits in Endog+/+ and Endog− /− fibroblasts and observed no differ-
ences (Fig. 5B). Because METC activity regulation can proceed inde-
pendently of METC complex abundance, we assessed O2 consumption of 
Endog+/+ and Endog− /− primary fibroblasts in vitro. We did not detect 
any genotype-dependent difference in basal, ATP-linked or maximal 
respiration (in presence of the uncoupler molecule FCCP), nor in the 
reserve respiratory capacity of these fibroblasts (Fig. 5C and D). Ubiq-
uinone/Coenzyme Q, a lipophilic molecule which transfers electrons 
from either Complex I or Complex II to Complex III, is involved in the 
regulation of mitochondrial respiration and ROS production, and its 
abundance is affected by mtDNA content [29]. We analyzed the content 
of Coenzyme Q9, the most abundant form of Ubiquinone in mouse cells, 
as well as its redox state and found no differences in either parameter 
comparing fibroblasts from Endog+/+ and Endog− /− mice (Fig. 5E). 
Together, these results show that EndoG does not influence ETC function 
nor the expression of ROS detoxifying enzymes in living cells and, 
therefore, its influence in ROS abundance must involve subtler 
mechanisms. 
Humanin (HN) is a micropeptide that has been claimed to be 
encoded by an open reading frame within the 16S ribosomal RNA gene 
(MT-RNR2) in the mtDNA [30]. HN addition to the culture medium 
reduced ROS accumulation and improved metabolism in several cell 
models as reviewed in Ref. [30,31]. Our previous results showed that 
nanomolar HN concentrations can restore ROS levels and cell size in 
Endog-deficient cardiomyocytes [15]. Therefore, we treated cultures of 
primary skin fibroblasts from Endog+/+ and Endog− /− mice with HN and 
assessed their proliferation. Direct cell counting showed that 100 nM HN 
restored the proliferative capacity of Endog− /− fibroblasts (Fig. 6A) 
without modifying ROS production (Fig. 6B). HN also restored the 
normal pAkt/Akt ratio and Cyclin D expression (Fig. 6C). Together these 
results showed that HN can bypass the effects of ROS production, 
restoring Akt phosphorylation and cell proliferation in EndoG-deficient 
cells. 
Inflammation is frequently associated with increased ROS [32,33] 
and mitochondrial DNA (mtDNA) stress has been shown to induce 
changes in nucleoid morphology, mtDNA release and activation of 
inflammation leading to the induction of IFN signaling and 
Interferon-stimulated gene 15 (Isg15) expression [34,35]. EndoG defi-
ciency induces a reduction in mtDNA content [15] and this event has 
been related to nucleoid morphology alteration and induction of Isg15 
expression in other experimental models [35]. Therefore, we wanted to 
explore the possibility that inflammation was present in EndoG-deficient 
cells. We assessed nucleoid morphology and distribution in Endog+/+
and Endog− /− primary skin fibroblasts and did not find any 
genotype-dependent difference (Fig. 7A). The transcripts of Irf7, which 
is frequently required in the pathway [35], and Isg15 were expressed at 
similar levels in wild type and EndoG-deficient cells (Fig. 7B). No 
changes in Irf7 or Isg15 expression related to Endog absence were 
observed in any tissue analyzed in adult mice (Fig. 7C). 
In search for alternative sources of ROS that could be influenced by 
EndoG, our interest was focused in Reactive Oxygen Species Modulator- 
1 (Romo1), a recently characterized inner mitochondrial membrane 
protein shown to be involved in ROS production and cell proliferation 
[36]. Although its function is still being characterized and its role in ROS 
production is debated [37–39], we decided to assess whether its 
expression could contribute to the changes in ROS production and cell 
proliferation observed in EndoG-deficient cells. Romo1 expression was 
Fig. 3. Quantification of the Influence of Endog 
expression in the distribution of proliferating non- 
synchronized cells throughout the cell cycle phases. 
A) Skin fibroblast cultures were obtained from P3 
Endog+/+ (n = 3) and Endog− /− (n = 6) mice and 
passaged two times. After 48 h in the plate, cells were 
detached, washed, fixed and stained with propidium 
iodide. The percentage of cells in each cell cycle 
phase was determined by flow cytometry. B) The 
same procedure was used for analyzing Rat-1 fibro-
blasts non transduced (NT) or transduced with 
scrambled (Scr) or Endog silencing constructs 1 and 2 
(Endog shRNA) from 5 experiments; and C) for cul-
tures of control HEK293 cells and HEK293 cell clones 
harboring a disruption of the ENDOG gene within 
exon 1 (4 experiments). Data depicted on stacked bar 
graphs are mean ± SEM. Statistical analysis was 
performed in A by the Student’s t-test, and in C and D 
by one-way ANOVA followed by the Bonferroni test 
(ns: not significant; *. p < 0.05; **, p < 0.01; ***, p <
0.001).   
N. Blasco et al.                                                                                                                                                                                                                                  
Redox Biology 37 (2020) 101736
8
similar in tissues of adult Endog+/+ and Endog− /− mice at the transcript 
level (Fig. 7D) and Romo1 gene silencing by shRNA-directed RNA 
interference reduced proliferation at similar levels in primary fibroblasts 
of both genotypes (Fig. 7E), without affecting ROS abundance (Fig. 7F). 
These results did not support a relevant contribution of Romo1 to the 
effects of EndoG in cell proliferation and ROS production, yet add novel 
information about this protein. 
4. Discussion 
The results presented here show that the mitochondrial nuclease 
EndoG is important for normal cell proliferation. A reduction of Endog 
expression slowed cell proliferation associated to an increase in ROS 
abundance, the accumulation of cells in the G1 phase of cell cycle and 
the reduction in the activity of the Akt-GSK-3β-Cyclin D axis. These ef-
fects were replicated in vivo in mouse cardiomyocytes, and in vitro in 
primary cell cultures, cell lines of rodent and human origin and by using 
Fig. 4. Analysis of the influence of Endog depletion in the expression of signal transduction and cell cycle proteins. A) Expression of cell cycle regulators involved in 
the control of G1/S (Akt, GSK3, and their phosphorylated forms pAkt and pGSK3, Cyclin D1, Cyclin E), and G2/M (CDK1 and its phosphorylated form pCDK1 and 
Cyclin B in total ventricular extracts of P0 and P3 Endog+/+ and Endog− /− neonatal mice. Densitometry analysis of the Western Blot bands is represented for key genes 
in the bar-graphs at right. Values are means (n = 3 ± SEM). A.U., arbitrary units. The Kruskal-Wallis test was performed followed by Dunnett’s test to compare all 
values vs. P0 Endog+/+. *, p < 0.005; **, p < 0.001; ***, p < 0.0001. B) Cyclin D immunostaining in ventricular histological preparations from Endog+/+ and Endog− / 
− neonatal mice. CyclinD+ nuclei were counted and referred to total nuclei in the graph at right. All 18 values from 6 hearts of each genotype are plotted. The Mann- 
Whitney U test was applied to check for significant differences. ***, p < 0.0001. C) The same cell cycle regulator proteins were analyzed in Rat-1 fibroblasts untreated 
(NT, not transduced), scrambled-transduced (Scr) and transduced with different Endog-specific silencing constructs (shRNA1 and 2) and D) in human HEK293 control 
cells and ENDOG-deficient clones using CRISPR-Cas9 technology to truncate ENDOG at two different regions (sgRNA1.1, sgRNA4.3; see Materials and Methods 
section for details). E) The effect of ROS scavenger N-Acetyl-L-Cysteine (NAC) on signaling proteins involved in cell cycle regulation was analyzed on protein extracts 
of ENDOG-deficient HEK293 clone sgRNA1.1 cells untreated or treated with 0.5 mM NAC for 12 and 24 h. Densitometry analysis of blots was performed and 
expression of key regulatory genes was referred to the values of untreated cells at time 0 in the graphs on the right. The Kruskal-Wallis test was performed followed by 
Dunn’s test to compare control and NAC-treated values for each time point. Blots are representative of 3–5 independent experiments. NB: Naphthol blue staining of 
the membranes. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
N. Blasco et al.                                                                                                                                                                                                                                  
Redox Biology 37 (2020) 101736
9
several methods for downregulating Endog gene expression ranging from 
in vivo gene knock-out, to RNA interference using either small hairpin- 
RNA lentiviral vectors and CRISPR-Cas9-driven gene targeting by ho-
mologous recombination in cell cultures. Addition of ROS scavengers 
NAC, GSH or MitoTEMPO™ reduced ROS accumulation in EndoG- 
deficient cells and recovered cell proliferation, Akt phosphorylation 
and Cyclin D expression, showing that ROS contribute significantly to 
the reduction of EndoG-deficient cell proliferation. The results also show 
that changes in mtDNA influence the increase in ROS occurring in 
EndoG-deficient cells, and that ROS increase is not due to changes in 
mitochondrial respiration, expression of ROS detoxifying enzymes, nor 
to mtDNA-induced inflammation. Furthermore, our results also show 
that Romo1, which is located in the same compartment than EndoG and 
has a debated role in cell proliferation and ROS production, does not 
mediate the effects of EndoG deficiency in these events. 
Previously, we identified the Endog gene as a determinant of cardiac 
hypertrophy and showed that EndoG is involved in the regulation of 
cardiomyocyte growth through the control of mitochondrial ROS pro-
duction [14]. However, cardiomyocyte hypertrophy was not fully 
translated into an overt increase of heart’s weight in Endog− /− mice 
[15]. Increased cell death in the EndoG-deficient heart could account for 
the above discrepancy. However, the original reports on two 
independent Endog− /− mouse models found no differences in the in-
duction of apoptosis compared to Endog+/+ cells [12,13]. In addition, 
our previous results showed that cardiomyocytes lacking Endog 
expression have less apoptotic nuclei, assessed both in vitro [17] and in 
vivo [40]. Therefore, we decided to further explore the cardiac pheno-
type of these mice and found a 30% reduction in cardiomyocyte number 
at birth, indicating that EndoG is important for normal cardiomyocyte 
proliferation during mouse’s heart development. ENDOG gene silencing 
was previously suggested to reduce the proliferation of HEK293 cells 
[23]. However, in that report the possible impact of the silencing 
method and the transformed nature of the human cell line used ques-
tioned the actual implication of EndoG in cell proliferation in this cell 
model. Here, the effect of Endog deletion in primary skin fibroblast 
proliferation in vitro showed a cell-autonomous role of EndoG in the 
regulation of cell proliferation, which was confirmed using several 
alternative strategies to reduce Endog expression and was demonstrated 
in several cell types. Thus, our results unequivocally demonstrate a 
cell-autonomous role of EndoG in cell proliferation. Increased ROS 
generation and decreased cell proliferation rate in EndoG-deficient cells 
was influenced by mtDNA, because mtDNA-depleted Rat1 fibroblasts 
did not experiment changes in ROS abundance nor in cell proliferation 
after Endog gene silencing. These results are in agreement with our 
Fig. 5. Analysis of the effects of EndoG deficiency in 
the expression of ROS metabolizing enzymes and 
METC complexes, cellular respiration and CoQ redox 
status. A) Expression of Catalase and Mn-Superoxide 
Dismutase in Endog+/+ and Endog− /− skin fibro-
blasts. B) Expression of electron transport chain sub-
units I to IV and ATP-synthase (CV) in Endog+/+ and 
Endog− /− skin fibroblasts (NB: Naphthol Blue). C) 
Oxygen consumption rate (OCR) of Endog+/+ (blue) 
and Endog− /− (red) cultures in the presence of Oli-
gomycin (ATP-synthase inhibitor), FCCP (METC-ATP 
synthase uncoupler), or Antimycin-A (Coenzyme-Q: 
Cytochrome-c Oxidoreductase, CIII, inhibitor). Data 
represent mean ± SD of 8 independent experiments 
comparing 2 Endog+/+ and 2 Endog− /− primary 
neonatal skin fibroblast cultures. D) ATP-linked 
respiration, reserve capacity and oxygen leak were 
measured in cultures of Endog+/+ (blue) and Endog− / 
− (red) skin fibroblast cultures from data presented in 
(C) following the methods described in the Materials 
and Methods section; individual experimental values 
are shown plus mean ± SD. E) Total coenzyme Q 
(CoQ9) and CoQ redox state (ratio of reduced CoQ vs. 
total CoQ) in Endog+/+ (blue) and Endog− /− (red) skin 
fibroblast cultures. Nine individual experimental 
measures are shown plus mean ± SD. Student’s t-test 
did not find significant effects of Endog expression on 
the experimental values. (For interpretation of the 
references to colour in this figure legend, the reader is 
referred to the Web version of this article.)   
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previous findings showing that ROS scavengers did not normalize 
mtDNA replication in Endog− /− mouse embryonic fibroblasts (MEF) 
[15]. The analysis of cell cycle consistently showed a tendency of 
EndoG-deficient cells to accumulate in the G1 phase, contrary to the G2 
arrest reported elsewhere [23]. This was accompanied by a reduction in 
both Akt and GSK-3β phosphorylation and decreased Cyclin D expres-
sion, which preceded Cyclin B downregulation in postnatal car-
diomyocytes. The AKT-dependent signaling pathway is involved in the 
control of the G1/S checkpoint and our results suggest that, by con-
trolling ROS abundance, EndoG is important for proliferating cells to 
successfully overcome this step of the cell cycle. 
ROS-dependent regulation of protein kinases and phosphatases in-
volves the reversible oxidation of key Cys residues and S-gluta-
thionylation [41–44], with impact in many aspects of cell biology. In 
particular, hydrogen peroxide-induced formation of a disulfide bond in 
Akt has been shown to inhibit Akt phosphorylation and induce apoptosis 
[42]. Furthermore, a recent report has identified an evolutionarily 
conserved mechanism of redox regulation of Ser/Thr kinases involving a 
conserved Cys in the activation segment, which can control the en-
zyme’s activity without affecting its phosphorylation [43]. The report 
shows that this redox sensitive regulation of protein kinase activity can 
affect, among many others, Akt and Aurora, which are important for the 
regulation of cell proliferation [43]. Increased ROS production in 
dividing EndoG-deficient cells shown here, and our previous results 
showing low amounts of free GSH in EndoG-deficient Rat-1 cells, which 
were restored by NAC addition [15] could be involved in the reduced 
phosphorylation of Akt and in the proliferation slow down due to EndoG 
deficiency through any of the mechanisms described by Murata and 
collaborators and Byrne and collaborators, and affect other key en-
zymes, which remain to be explored. 
ROS are known to influence cell proliferation at many levels [45]. 
Due to the involvement of ROS in the effects of EndoG deficiency on cell 
proliferation, we investigated the possible alterations leading to an in-
crease in the abundance of these molecules. The mitochondrial location 
of EndoG and previous findings suggesting changes in METC complex 
activity in isolated mitochondria of Endog− /− cells [14], despite a lack of 
changes in the in vitro activity of isolated METC complexes [15], 
prompted us to analyze potential alterations of METC function as the 
source of ROS in living cells. However, neither changes in the oxygen 
consumption rate, nor in any measured parameter related to the func-
tion and coupling of the METC were found in intact primary Endog− /−
skin fibroblasts. Mitochondrial MnSOD and catalase are important ROS 
detoxifying enzymes [26,46], but their expression was unaffected by 
EndoG deficiency. Humanin is a 2.4 kDa micropeptide suggested to be 
codified by the mtDNA [30], and having antioxidative effects [47]. Our 
previous results showed that addition of HN normalized ROS abundance 
and growth in postnatal mouse Endog− /− and Endog-specific shRNA 
treated rat cardiomyocytes [15], but in proliferative cells, the results 
presented here show that HN restores the proliferation rate, Akt 
signaling pathway’s activity and cyclin expression without affecting 
ROS abundance. Indeed, HN was shown previously to induce Akt 
phosphorylation through the interaction with GP130/IL6ST receptor 
Fig. 6. Effects of Humanin addition on the effects 
caused by EndoG deficiency in cell proliferation, ROS 
production and signal transduction. A) Equal number 
of Endog+/+ and Endog− /− mouse-derived skin fibro-
blasts were seeded. At time zero, cell number in 
replicate plaques was counted. DMSO (Control) or 
100 nM Humanin (HN) diluted in DMSO were added 
in duplicate plates/treatment and cells were counted 
after 48 h. Data are expressed as the number of cell 
cycles completed in 48 h. All values from 5 inde-
pendent experiments in duplicates are plotted. B) 
MitoSOX™ fluorescence was quantified by flow 
cytometry in preparations of the same experimental 
groups as in (A). Eight experiments for controls and 
four experiments for HN treatment in duplicates are 
plotted. C) Western Blot of pAkt, total Akt and EndoG 
was performed with cultures of primary skin fibro-
blasts of 6 Endog+/+ and 6 Endog− /− adult mice (NB: 
Naphthol blue staining of the membrane). After 
densitometric quantification of pAkt and Akt Western 
Blot bands, the ratio was calculated for each sample 
and plotted in the graph at right. Data in all the 
graphs represent individual values, mean ± SD 
(Endog+/+, blue dots; Endog− /− , red dots). Two-way 
ANOVA was used to analyze the influence of Endog 
expression and Humanin treatment and the interac-
tion between them in cell proliferation, ROS produc-
tion and Akt phosphorylation. Ns: not significant; *, p 
< 0.05; **, p < 0.01; ***, p < 0.001; ****, p <
0.0001. (For interpretation of the references to colour 
in this figure legend, the reader is referred to the Web 
version of this article.)   
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complex [30]. Taken together, these results suggest that HN could 
disrupt the effect of ROS on Akt signaling, allowing normal proliferation 
in EndoG-deficient cells. 
Oxidative stress is associated with inflammation, and mtDNA stress 
has been shown to induce inflammation and the expression of IFN- 
dependent genes [34,35]. In particular, Tfam deficiency was shown to 
trigger a 50% reduction of the mtDNA content inducing changes in 
nucleoid morphology, the release of mtDNA to the cytosol, and the 
activation of the IFN signaling pathway leading to increased expression 
of Isg15 in MEFs [35]. However, EndoG deficiency, which causes a 30% 
reduction in mtDNA content [14], did not affect nucleoid morphology 
and the expression of Irf7 and Isg15 neither in cultured skin fibroblasts, 
nor in adult mouse tissues, to a detectable extent. These results suggest 
that in EndoG-deficient cells either the defect in mtDNA is not sufficient 
to induce changes in the morphology of nucleoids and Isg15 expression, 
or that the effects depend on the cell type. Recently, Endog− /− MEFs 
have been used as a model to show induction of the IFN-dependent 
signaling allegedly in the absence of alterations in the mtDNA content 
and cell proliferation [48]. Unfortunately, the authors did not contrast 
their results with those previously published by us showing that EndoG 
deficiency does lead to a reduction in the mtDNA content [14], and 
induces a defect in mtDNA replication in cardiomyocytes and primary 
MEFs [15]. In addition, the results shown in the present work discard 
any change in Isg15 expression related to Endog expression in postnatal 
fibroblasts and adult tissues in vivo. One possible explanation for the 
discrepancies on the mtDNA content, proliferation rate and Isg15 
expression between the work published by Kim and co-workers and our 
previous and present results could be the use of immortalized Endog− /−
MEFs by these authors. However, contrary to the identification of other 
MEF lines used in their article, the source of Endog-/- MEFs was not 
specified. In any case, our data robustly demonstrate that EndoG defi-
ciency does induce changes in mtDNA content and in cell proliferation 
without affecting nucleoid morphology and Isg15 gene expression. In 
fact, another report showed that a 50% reduction of mtDNA abundance 
induced by Opa-1 gene deletion triggered changes in nucleoid 
morphology but neither induced mtDNA release, nor activation of Isg15 
expression [49]. Together with previous data published elsewhere, our 
results demonstrate that important mtDNA stress is not always directly 
related to the activation of the IFN pathway. 
Reactive oxygen species modulator-1, Romo1/MTGM, a nuclearly 
encoded inner mitochondrial membrane protein, has been shown to be 
required for or to inhibit ROS production [37,50] and to stimulate [36, 
39] or to hamper [51] cell proliferation. Our results show that Romo1 
silencing induces a similar reduction in cell proliferation in Endog+/+
and Endog− /− skin fibroblasts without significant effects on ROS abun-
dance, suggesting that Romo1 is not involved in the role of EndoG in the 
regulation of ROS and cell proliferation. Thus, our data contribute to the 
understanding of Romo1 biological roles by showing that Romo1 is 
important for cell proliferation and dispensable for ROS biology, in 
agreement with Richter’s group results [39]. 
In conclusion, our results show that the mitochondrial nuclease 
EndoG is required for normal cell proliferation through the control of 
ROS-dependent signaling. They also suggest that the increase of ROS 
abundance in EndoG-deficient cells hamper Akt phosphorylation and 
Akt-dependent progression through the G1/S cell cycle checkpoint. The 
micropeptide Humanin can overcome the effect of ROS and recover 
normal proliferation rate in the absence of EndoG. Our results also show 
that low mtDNA due to EndoG deficiency does not trigger IFN- 
dependent inflammation, and that the mitochondrial protein Romo1 is 
required for normal cell division independently of EndoG. Therefore, in 
addition to point to EndoG as an important gene for the control of cell 
proliferation through the control of ROS production, our data contribute 
to improve the knowledge on the biological roles of Humanin and 
Romo1. 
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Fig. 7. Analysis of mitochondrial DNA nucleoid morphology and expression of Interferon pathway’s markers in EndoG deficient cells, and assessment of the role of 
Romo1 expression and function in cell proliferation and ROS production. A) Double strand DNA (nucleoids, green) and mitochondria (TOM20 staining, red) were 
imaged as described in the Materials and Methods section in primary cultures of skin fibroblast obtained from Endog+/+ and Endog− /− mice. Representative composite 
images of a single cell for each genotype are presented in the panels (insets are a magnification of the picture for detail). Nucleoid area, area group distribution and 
colocalization with mitochondria (Mander’s coefficient) for Endog+/+ (blue) and Endog− /− (red) measured and calculated from 42 dermal fibroblasts per genotype 
from 6 independent animals are shown in the graphs plus mean ± SD. B) Expression of interferon pathway markers Irf7 and Isg15 was quantified in total RNA extracts 
obtained from cultured skin fibroblast of Endog+/+ (blue) and Endog− /− (red) mice. N = 6, dots are individual measurements performed in duplicate and corrected by 
Gapdh expression, median with interquartile range is indicated. Mann-Whitney U test was performed. C) Irf7 and Isg15 mRNA expression was quantified also in 
several tissues of Endog+/+ (blue) and Endog− /− (red) mice (N = 3/genotype). H: Heart, B: Brain, K: Kidney, L: Lung, S: Spleen, Li: Liver, M: Skeletal muscle. Bars 
represent min to max. values plus median of data referred to Heart. D) Romo1 mRNA expression was quantified in the same samples as in C. Bars represent min to 
max. values plus median of data referred to Heart. In C) and D) the Kruskal-Wallis test followed by Dunn’s post hoc test was performed showing no influence of Endog 
expression in the expression of Irf7, Isg15 and Romo1. E) Endog+/+ and Endog− /− mouse-derived skin fibroblasts transduced with a scrambled shRNA or a mixture of 2 
independent Romo1-specific shRNA and equal amounts of cells were seeded. At time zero, cell number in replicate plaques was counted to confirm equal cell number 
and the rest of plates were counted after 72 h. Data are expressed as the number of cell cycles completed in 72 h. All values from 5 independent experiments are 
plotted. F) MitoSOX™ fluorescence was quantified by flow cytometry in preparations of the same experimental groups as in (E). All values from six experiments are 
plotted. In E and F mean ± SD are also indicated. Two-way ANOVA was used to analyze the influence of Endog and Romo1 expression and the interaction between 
them in cell proliferation and ROS abundance. Ns: not significant; ***, p < 0.001; ****, p < 0.0001. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the Web version of this article.) 
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